Skip to main content
TipRanks
Go Ultimate75% OFF

MedFirst Healthcare Services, Inc. (TW) (4175) AI Stock Analysis

TW:4175

MedFirst Healthcare Services, Inc. (TW)

(TPEx:4175)

Select Model
Rating:62Neutral
Price Target:TWD 52.00â–²(4.00% Upside)
Action:initiatedcoverage
Date:11/10/26

The overall score of 62 reflects a company with strong fundamentals and attractive valuation offset by weak market sentiment. The primary strength is the compelling valuation, with a low P/E ratio and a very high, well-covered dividend yield. The company's financial performance is a secondary positive, driven by a powerful operational turnaround and surging free cash flow. The most significant risk is the bearish technical picture, with the stock in a clear downtrend across all timeframes, which heavily pressures the score.

Positive Factors
Strong Revenue GrowthThe sharp 2025 revenue acceleration indicates materially expanding business activity and provides a stronger base for future earnings growth. If the higher sales level is maintained, it can improve operating scale, support investment, and strengthen the company’s position over the next several quarters.
Negative Factors
Thin Net ProfitabilityA net margin of only 1.9% leaves limited room to absorb cost increases, weaker demand, or execution setbacks. Even with year-over-year improvement, the company converts a relatively small share of revenue into profit, which can make earnings less resilient and constrain internally funded growth.

MedFirst Healthcare Services, Inc. (TW) (4175) vs. SPDR S&P 500 ETF (SPY)

-10%-5%0%5%10%15%20%TW:4175-7.23%SPY+14.28%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
TWD 2.11B
Dividend Yield
6.00%
Average Volume (3M)
11.04K
Price to Earnings (P/E)
13.2
Beta (1Y)
0.21
Revenue Growth
2.49%
EPS Growth
5.18%
Country
TW
Employees
150
Sector
General
Sector Strength
55
Industry
Medical - Distribution

MedFirst Healthcare Services, Inc. (TW) Business Overview & Revenue Model

Company Description

MedFirst Healthcare Services, Inc., established in 1990 and headquartered in Taoyuan City, Taiwan, is a prominent distributor of medical supplies throughout Taiwan and China. The company's diverse product range includes diabetes management items, res...

MedFirst Healthcare Services, Inc. (TW) Financial Statement Overview

Summary

Financial performance is mixed. The income statement and cash flow show a powerful turnaround with surging revenue and robust free cash flow, indicating high-quality earnings. However, the balance sheet remains highly leveraged with a debt-to-equity ratio of 2.30x, which is a significant risk. The strong cash generation partially mitigates this concern, resulting in a moderately positive score.

Income Statement

72Positive

Balance Sheet

55Neutral

Cash Flow

78Positive
Financial statement breakdown
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue8.06B8.01B7.73B7.45B7.22B6.54B
Gross Profit2.65B2.60B2.38B2.27B2.21B1.93B
EBITDA794.07M991.07M924.25M873.32M940.99M686.17M
Net Income160.34M155.57M69.81M46.80M170.86M67.93M
Balance Sheet
Total Assets7.31B7.28B7.12B7.63B7.55B6.81B
Cash, Cash Equivalents and Short-Term Investments570.70M533.99M624.58M961.38M1.01B841.36M
Total Debt3.52B3.59B3.64B3.88B3.94B3.61B
Total Liabilities5.78B5.72B5.66B6.18B6.19B5.63B
Stockholders Equity1.52B1.56B1.46B1.45B1.36B1.17B
Cash Flow
Free Cash Flow850.53M624.41M404.82M572.08M805.35M587.94M
Operating Cash Flow982.35M903.97M542.24M795.40M1.07B1.00B
Investing Cash Flow-167.87M-307.49M-207.97M-253.30M-221.49M-397.75M
Financing Cash Flow-818.76M-715.11M-754.72M-603.48M-611.30M-188.06M

MedFirst Healthcare Services, Inc. (TW) Peers Comparison

Overall Rating

UnderperformOutperform
Sector (55)

Financial Indicators

TW:4175 against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
TW:4138TW:413868NeutralTWD 2.15B15.66―7.75%-1.10%-16.90%
TW:4155TW:415564NeutralTWD 2.19B10.00―1.78%-10.90%―
TW:4175TW:417562NeutralTWD 2.09B13.16―6.00%2.49%5.18%
Sector *55Neutral$6.65B3.83-15.92%6.20%10.91%7.18%
TW:4747TW:474753NeutralTWD 1.60B-23.25―3.32%4.56%-172.55%
TW:4108TW:410847NeutralTWD 2.06B-48.44――1.10%54.83%
TW:6796TW:679640UnderperformTWD 2.04B123.00―0.51%12.26%―

* General Sector Average

Performance Comparison

-40%-20%0%20%TW:4175TW:4108TW:4138TW:4155TW:4747TW:6796Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
TW:4175 and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
TW:4175MedFirst Healthcare Services, Inc. (TW)50.00-4.37-8.04%
TW:4108Phytohealth Corporation10.40-3.85-27.02%
TW:4138Dynamic Medical Technologies Inc.54.20-5.51-9.23%
TW:4155Ok Biotech Co., Ltd.16.901.529.91%
TW:4747Johnson Chemical Pharmaceutical Works Co., Ltd.15.80-15.92-50.19%
TW:6796Medimaging Integrated Solution Inc.49.20-40.22-44.98%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Nov 09, 2026